Stryker Co. (NYSE:SYK) Shares Sold by California State Teachers Retirement System

California State Teachers Retirement System cut its stake in shares of Stryker Co. (NYSE:SYK - Free Report) by 2.3% during the 4th quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 542,174 shares of the medical technology company's stock after selling 12,686 shares during the period. California State Teachers Retirement System owned about 0.14% of Stryker worth $195,210,000 at the end of the most recent quarter.

Other institutional investors and hedge funds also recently bought and sold shares of the company. Kohmann Bosshard Financial Services LLC purchased a new position in Stryker during the fourth quarter valued at $25,000. Rakuten Securities Inc. lifted its position in Stryker by 618.2% during the fourth quarter. Rakuten Securities Inc. now owns 79 shares of the medical technology company's stock valued at $28,000 after purchasing an additional 68 shares in the last quarter. Centricity Wealth Management LLC purchased a new position in shares of Stryker in the fourth quarter valued at about $30,000. BankPlus Trust Department purchased a new position in shares of Stryker in the fourth quarter valued at about $33,000. Finally, Activest Wealth Management purchased a new position in shares of Stryker in the fourth quarter valued at about $36,000. 77.09% of the stock is currently owned by hedge funds and other institutional investors.

Wall Street Analysts Forecast Growth

SYK has been the topic of several research analyst reports. StockNews.com downgraded Stryker from a "buy" rating to a "hold" rating in a research report on Thursday, March 6th. Argus set a $450.00 target price on Stryker in a research report on Monday, February 3rd. Wells Fargo & Company boosted their price objective on Stryker from $427.00 to $435.00 and gave the stock an "overweight" rating in a research note on Wednesday, January 29th. Barclays boosted their price objective on Stryker from $418.00 to $443.00 and gave the stock an "overweight" rating in a research note on Monday, February 10th. Finally, Citigroup reissued a "buy" rating and set a $450.00 price objective on shares of Stryker in a research note on Wednesday, February 26th. Five equities research analysts have rated the stock with a hold rating and fifteen have assigned a buy rating to the stock. According to MarketBeat, Stryker currently has an average rating of "Moderate Buy" and an average price target of $423.53.

Insider Transactions at Stryker

In other news, Director Allan C. Golston sold 2,458 shares of the company's stock in a transaction that occurred on Tuesday, February 18th. The stock was sold at an average price of $383.07, for a total transaction of $941,586.06. Following the completion of the transaction, the director now directly owns 14,895 shares of the company's stock, valued at $5,705,827.65. This represents a 14.16 % decrease in their position. The sale was disclosed in a filing with the SEC, which is available through this link. Also, Director Ronda E. Stryker sold 201,392 shares of the firm's stock in a transaction dated Friday, January 31st. The stock was sold at an average price of $392.24, for a total transaction of $78,993,998.08. Following the completion of the transaction, the director now directly owns 3,642,075 shares in the company, valued at approximately $1,428,567,498. This represents a 5.24 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Corporate insiders own 5.90% of the company's stock.

Stryker Price Performance

Shares of SYK stock traded up $3.14 during trading hours on Wednesday, hitting $374.06. 2,251,733 shares of the company's stock were exchanged, compared to its average volume of 1,353,911. The company has a quick ratio of 1.32, a current ratio of 1.95 and a debt-to-equity ratio of 0.59. The firm has a market cap of $142.77 billion, a P/E ratio of 48.20, a P/E/G ratio of 2.93 and a beta of 0.93. The firm has a 50 day moving average of $366.89 and a two-hundred day moving average of $373.50. Stryker Co. has a fifty-two week low of $314.93 and a fifty-two week high of $406.19.

Stryker (NYSE:SYK - Get Free Report) last announced its earnings results on Tuesday, January 28th. The medical technology company reported $4.01 earnings per share for the quarter, topping the consensus estimate of $3.87 by $0.14. Stryker had a return on equity of 23.58% and a net margin of 13.25%. During the same quarter in the prior year, the business posted $3.46 earnings per share. Sell-side analysts forecast that Stryker Co. will post 13.47 EPS for the current year.

Stryker Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Wednesday, April 30th. Stockholders of record on Monday, March 31st will be paid a dividend of $0.84 per share. This represents a $3.36 annualized dividend and a dividend yield of 0.90%. The ex-dividend date of this dividend is Monday, March 31st. Stryker's payout ratio is 43.30%.

Stryker Profile

Stryker Corporation operates as a medical technology company. The company operates through two segments, MedSurg and Neurotechnology, and Orthopaedics and Spine. The Orthopaedics and Spine segment provides implants for use in total joint replacements, such as hip, knee and shoulder, and trauma and extremities surgeries.